Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016
Objective To analyse voluntary payment reports of pharmaceutical companies to German healthcare professionals (HCPs) in 2015 and 2016 based on an industry-self-regulating transparency codex.Design and participants Cohort study of all German HCPs who voluntarily agreed that at least one payment they...
Saved in:
| Main Authors: | Marlene Stoll, Lara Hubenschmid, Cora Koch, Klaus Lieb |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-09-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/9/e037395.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012–2016)
by: Piotr Ozieranski, et al.
Published: (2020-09-01) -
VOLUNTARY DISCLOSURE IN INDONESIA: COMPARISON OF SHARIAH AND NON-SHARIAH COMPLIANT COMPANIES
by: Peni Nugraheni
Published: (2016-01-01) -
Voluntary disclosure and firm value: Evidence from Indonesia
by: Hadi Mahmudah, et al.
Published: (2023-12-01) -
The effect of voluntary disclosure and financial distress on audit delay
by: Putri Nurmala, et al.
Published: (2023-09-01) -
Voluntary Disclosure: The Role of Institutional Ownership as a Moderating Variable Between Carbon Emission Disclosure to Financial Performance
by: Brilliani Brilliani, et al.
Published: (2024-01-01)